Product Description
Temazepam is a benzodiazepine drug which is a minor metabolite of diazepam. In clinical studies using subjective evaluation methods it was effective for maintaining sleep and increasing total sleep time. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/6112127/)
Mechanisms of Action: GABA Modulator
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Bangladesh | Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Finland | Germany | Hungary | India | Ireland | Italy | Malta | Mexico | Netherlands | New Zealand | Pakistan | Peru | Poland | Portugal | Russia | South Africa | Spain | Switzerland | Taiwan | United Arab Emirates | United Kingdom | United States | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|